Prudential Financial’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.65M | Buy |
35,268
+11,260
| +47% | +$889K | ﹤0.01% | 1194 |
|
|
2025
Q4 | $1.9M | Buy |
24,008
+14,664
| +157% | +$1.1M | ﹤0.01% | 1340 |
|
|
2025
Q3 | $611K | Buy |
9,344
+90
| +1% | +$4.39K | ﹤0.01% | 1856 |
|
|
2025
Q2 | $341K | Buy |
9,254
+2,991
| +48% | +$97.9K | ﹤0.01% | 2064 |
|
|
2025
Q1 | $210K | Buy |
+6,263
| New | +$205K | ﹤0.01% | 2065 |
|
|
2024
Q4 | – | Sell |
-90,017
| Closed | -$3.61M | – | 2489 |
|
|
2024
Q3 | $3.61M | Buy |
90,017
+74,300
| +473% | +$3.46M | 0.01% | 1153 |
|
|
2024
Q2 | $749K | Buy |
+15,717
| New | +$645K | ﹤0.01% | 1994 |
|
|
2024
Q1 | – | Sell |
-4,269
| Closed | -$216K | – | 2708 |
|
|
2023
Q4 | $216K | Buy |
+4,269
| New | +$204K | ﹤0.01% | 2419 |
|
|
2022
Q4 | – | Sell |
-5,098
| Closed | -$226K | – | 2657 |
|
|
2022
Q3 | $226K | Buy |
+5,098
| New | +$215K | ﹤0.01% | 2417 |
|
|
2021
Q4 | – | Sell |
-5,763
| Closed | -$214K | – | 2662 |
|
|
2021
Q3 | $214K | Buy |
5,763
+611
| +12% | +$23K | ﹤0.01% | 2453 |
|
|
2021
Q2 | $205K | Sell |
5,152
-4,366
| -46% | -$171K | ﹤0.01% | 2447 |
|
|
2021
Q1 | $428K | Sell |
9,518
-36,009
| -79% | -$2.01M | ﹤0.01% | 2175 |
|
|
2020
Q4 | $2.57M | Sell |
45,527
-6,708
| -13% | -$334K | ﹤0.01% | 1306 |
|
|
2020
Q3 | $2.48M | Buy |
52,235
+6,611
| +14% | +$367K | ﹤0.01% | 1235 |
|
|
2020
Q2 | $2.69M | Buy |
45,624
+38,003
| +499% | +$2.11M | 0.01% | 1212 |
|
|
2020
Q1 | $361K | Buy |
7,621
+1,955
| +35% | +$109K | ﹤0.01% | 2005 |
|
|
2019
Q4 | $342K | Sell |
5,666
-10,060
| -64% | -$599K | ﹤0.01% | 2167 |
|
|
2019
Q3 | $942K | Sell |
15,726
-2,100
| -12% | -$137K | ﹤0.01% | 1875 |
|
|
2019
Q2 | $1.15M | Sell |
17,826
-310
| -2% | -$21.9K | ﹤0.01% | 1837 |
|
|
2019
Q1 | $1.47M | Buy |
18,136
+9,441
| +109% | +$609K | ﹤0.01% | 1736 |
|
|
2018
Q4 | $470K | Sell |
8,695
-103
| -1% | -$5.25K | ﹤0.01% | 2017 |
|
|
2018
Q3 | $454K | Buy |
8,798
+457
| +5% | +$21.5K | ﹤0.01% | 2069 |
|
|
2018
Q2 | $348K | Buy |
8,341
+1,900
| +29% | +$84.2K | ﹤0.01% | 2147 |
|
|
2018
Q1 | $284K | Hold |
6,441
| – | – | ﹤0.01% | 2167 |
|
|
2017
Q4 | $324K | Sell |
6,441
-2,800
| -30% | -$154K | ﹤0.01% | 2120 |
|
|
2017
Q3 | $469K | Buy |
9,241
+600
| +7% | +$31.4K | ﹤0.01% | 2027 |
|
|
2017
Q2 | $440K | Buy |
8,641
+400
| +5% | +$18.6K | ﹤0.01% | 2055 |
|
|
2017
Q1 | $331K | Buy |
8,241
+2,200
| +36% | +$98.8K | ﹤0.01% | 2121 |
|
|
2016
Q4 | $289K | Sell |
6,041
-300
| -5% | -$11.9K | ﹤0.01% | 2162 |
|
|
2016
Q3 | $232K | Buy |
+6,341
| New | +$198K | ﹤0.01% | 2185 |
|
|
2016
Q2 | – | Sell |
-6,051
| Closed | -$245K | – | 2309 |
|
|
2016
Q1 | $245K | Hold |
6,051
| – | – | ﹤0.01% | 2156 |
|
|
2015
Q4 | $375K | Buy |
6,051
+160
| +3% | +$8.63K | ﹤0.01% | 2034 |
|
|
2015
Q3 | $238K | Buy |
5,891
+700
| +13% | +$36.2K | ﹤0.01% | 2095 |
|
|
2015
Q2 | $299K | Sell |
5,191
-5,752
| -53% | -$366K | ﹤0.01% | 2058 |
|
|
2015
Q1 | $697K | Sell |
10,943
-140
| -1% | -$9.5K | ﹤0.01% | 1922 |
|
|
2014
Q4 | $684K | Sell |
11,083
-1,100
| -9% | -$54.3K | ﹤0.01% | 1860 |
|
|
2014
Q3 | $473K | Sell |
12,183
-37,502
| -75% | -$1.33M | ﹤0.01% | 1930 |
|
|
2014
Q2 | $1.71M | Buy |
49,685
+11,402
| +30% | +$359K | ﹤0.01% | 1599 |
|
|
2014
Q1 | $1.65M | Buy |
38,283
+8,400
| +28% | +$407K | ﹤0.01% | 1565 |
|
|
2013
Q4 | $1.19M | Buy |
29,883
+6,360
| +27% | +$227K | ﹤0.01% | 1677 |
|
|
2013
Q3 | $883K | Buy |
23,523
+200
| +0.9% | +$5.97K | ﹤0.01% | 1787 |
|
|
2013
Q2 | $627K | Buy |
+23,323
| New | +$496K | ﹤0.01% | 1872 |
|
Other funds holding IONS
VPM
VCM
Prudential Financial's IONS Position: Q1 2026 in Review
Prudential Financial increased its Ionis Pharmaceuticals (IONS) stake by 47% in Q1 2026, buying an estimated $889K and bringing the position to 35,268 shares worth $2.65M. The position accounts for ﹤0.01% of the portfolio, ranked #1194.
Prudential Financial first reported a position in IONS in Q2 2013 and has held it in 42 quarters since. The position peaked at $3.61M in Q3 2024. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.
- Prudential Financial held 35,268 shares of Ionis Pharmaceuticals worth $2.65M as of Q1 2026.
- Prudential Financial bought 11,260 Ionis Pharmaceuticals shares in Q1 2026, an estimated $889K.
- Ionis Pharmaceuticals made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #1194 holding.
- Prudential Financial first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 42 quarters since.
- Prudential Financial's Ionis Pharmaceuticals position peaked at $3.61M in Q3 2024.
- 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.
Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.